OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
Karin M. Knudson, Kristin C. Hicks, Yohei Ozawa, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000493-e000493
Open Access | Times Cited: 37
Karin M. Knudson, Kristin C. Hicks, Yohei Ozawa, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000493-e000493
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
Implications of glycosylation for the development of selected cytokines and their derivatives for medical use
Giovanna Scapin, Ece Cagdas, Lise Marie Grav, et al.
Biotechnology Advances (2024) Vol. 77, pp. 108467-108467
Open Access
Giovanna Scapin, Ece Cagdas, Lise Marie Grav, et al.
Biotechnology Advances (2024) Vol. 77, pp. 108467-108467
Open Access
Targeted LNPs deliver IL-15 superagonists mRNA for precision cancer therapy
Juntao Yu, Quan Li, Chaoting Zhang, et al.
Biomaterials (2024) Vol. 317, pp. 123047-123047
Closed Access
Juntao Yu, Quan Li, Chaoting Zhang, et al.
Biomaterials (2024) Vol. 317, pp. 123047-123047
Closed Access
The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination
Nabila Seddiki, Florence Picard, Léa Dupaty, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 419-419
Open Access | Times Cited: 3
Nabila Seddiki, Florence Picard, Léa Dupaty, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 419-419
Open Access | Times Cited: 3
Immune Activation Effects at Different Irradiated Sites and Optimal Timing of Radioimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer: a Real-World Analysis
Min Wu, Shihao Wu, Yuetong Chen, et al.
Biological Procedures Online (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Min Wu, Shihao Wu, Yuetong Chen, et al.
Biological Procedures Online (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo
Stella Martomo, Jeegar Patel
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 6, pp. 1941-1950
Open Access | Times Cited: 2
Stella Martomo, Jeegar Patel
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 6, pp. 1941-1950
Open Access | Times Cited: 2
Myeloid-Derived Suppressor Cells and Cancer Metastasis
Amene Saghazadeh, Nima Rezaei
Springer eBooks (2023), pp. 1-29
Closed Access
Amene Saghazadeh, Nima Rezaei
Springer eBooks (2023), pp. 1-29
Closed Access
Fine-Tuning the Immune Response Against Cancer with Antibody-Cytokine Fusion Proteins
Sol Ferrero, Matías Gatto, Gustavo Helguera
Springer eBooks (2023), pp. 1-28
Closed Access
Sol Ferrero, Matías Gatto, Gustavo Helguera
Springer eBooks (2023), pp. 1-28
Closed Access
Mathematical modeling indicates that regulatory inhibition of CD8+T cell cytotoxicity can limit efficacy of IL-15 immunotherapy in cases of high pre-treatment SIV viral load
Jonathan W. Cody, Amy Ellis, Shelby L. O’Connor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Jonathan W. Cody, Amy Ellis, Shelby L. O’Connor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Immune activation effects at different irradiated sites and optimal timing of radioimmunotherapy in patients with extensive-stage small cell lung cancer: a real-world analysis
Min Wu, Shihao Wu, Yuetong Chen, et al.
Research Square (Research Square) (2023)
Open Access
Min Wu, Shihao Wu, Yuetong Chen, et al.
Research Square (Research Square) (2023)
Open Access
Mathematical modeling indicates that regulatory inhibition of CD8+ T cell cytotoxicity can limit efficacy of IL-15 immunotherapy in cases of high pre-treatment SIV viral load
Jonathan W. Cody, Amy Ellis, Shelby L. O’Connor, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 8, pp. e1011425-e1011425
Open Access
Jonathan W. Cody, Amy Ellis, Shelby L. O’Connor, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 8, pp. e1011425-e1011425
Open Access
Vaccines and Immunomodulators
Jeffrey Schlom, Sofia R. Gameiro, Claudia Palena, et al.
Holland‐Frei Cancer Medicine (2022), pp. 1-8
Closed Access
Jeffrey Schlom, Sofia R. Gameiro, Claudia Palena, et al.
Holland‐Frei Cancer Medicine (2022), pp. 1-8
Closed Access
